120 related articles for article (PubMed ID: 219564)
1. Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases.
Enck RE; Betts RF; Brown MR; Miller G
Transfusion; 1979; 19(1):32-8. PubMed ID: 219564
[No Abstract] [Full Text] [Related]
2. Antibodies against Australia-antigen in haemophilia.
Nordenfelt E; Nilsson IM
Rev Eur Etud Clin Biol; 1971 Feb; 16(2):151-5. PubMed ID: 5313698
[No Abstract] [Full Text] [Related]
3. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.
Schulman S; Wiechel B
Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281
[TBL] [Abstract][Full Text] [Related]
4. Viral exposure and abnormal liver function in haemophilia.
McVerry BA; Ross MG; Knowles WA; Voke J
J Clin Pathol; 1979 Apr; 32(4):377-81. PubMed ID: 221550
[TBL] [Abstract][Full Text] [Related]
5. Liver dysfunction in patients with hemophilia A, B, and von Willebrand's disease.
Hilgartner MW; Giardina P
Transfusion; 1977; 17(5):495-9. PubMed ID: 302996
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in haemophilia and von Willebrand's disease.
Passaleva A; Massai G; Morfini M; Longo G; Rossi Ferrini PL; Ricci M
Scand J Haematol; 1983 Nov; 31(5):466-74. PubMed ID: 6606214
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis A antibodies in young hemophiliacs].
Schiller WG; Doroshenko NW; Stakhanova VM; Remde W
Z Gesamte Inn Med; 1985 Mar; 40(6):183-5. PubMed ID: 3873754
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cytomegalovirus and Epstein-Barr virus antibody responses in treated hemophiliacs. Implications for the study of acquired immune deficiency syndrome.
Cheeseman SH; Sullivan JL; Brettler DB; Levine PH
JAMA; 1984 Jul; 252(1):83-5. PubMed ID: 6328057
[TBL] [Abstract][Full Text] [Related]
9. Immunologic studies in hereditary hemorrhagic diseases.
Enck RE; Condemi JJ
Mil Med; 1979 Feb; 144(2):114-6. PubMed ID: 106333
[No Abstract] [Full Text] [Related]
10. [Characterization of immune disorders in hemophiliac patients with the identification of inhibitor-dependence in replacement transfusion therapy].
Rudenko VP; Stasyshyn OV; Lebed' HB; Orlyk VV; Lohins'kyĭ VIe
Lik Sprava; 2001; (3):39-43. PubMed ID: 11560024
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes in hemophilia.
Poskitt TR; Poskitt PK; Bean CA; Arkel YS
Am J Hematol; 1981 Sep; 11(2):147-52. PubMed ID: 6795922
[TBL] [Abstract][Full Text] [Related]
12. Liver dysfunction in haemophilia A, B and other hereditary haemorrhagic disorders.
Ng HW
Ann Acad Med Singap; 1984 Jul; 13(3):524-6. PubMed ID: 6335008
[TBL] [Abstract][Full Text] [Related]
13. [Hemophilia. New aspects in diagnosis and treatment].
Gormsen J
Ugeskr Laeger; 1973 Nov; 135(46):2487-93. PubMed ID: 4592776
[No Abstract] [Full Text] [Related]
14. [NANB-hepatitis associated marker ("C") in hemophilia].
Renger FG; Wendtland H; Schiller WG
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(6):887-93. PubMed ID: 6200401
[TBL] [Abstract][Full Text] [Related]
15. [Incidence of hepatitis B in hemophilia patients].
Thoms J; Berles R; Syrbe G
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):523-9. PubMed ID: 2446993
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of Australia antigen and antibody in haemophilia.
Essien EM; Smith JA; Francis TI
Acta Haematol; 1973; 50(5):293-8. PubMed ID: 4202633
[No Abstract] [Full Text] [Related]
17. Alteration of T lymphocyte subpopulations in Swedish hemophiliacs.
Biberfeld G; Blombäck M; Egberg N; Lenkei R; Nilsson IM; Porwit-Ksiazek A
Scand J Haematol Suppl; 1984; 40():379-82. PubMed ID: 6332375
[No Abstract] [Full Text] [Related]
18. Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with bleeding disorders.
Anh-Tuan N; Novák E; Hollán SR
Vox Sang; 1981 Jan; 40(1):12-6. PubMed ID: 6971526
[TBL] [Abstract][Full Text] [Related]
19. Haemophilia in children. Current immunologic status of a pediatric population.
Carnelli V; Giulotto P; Magnolfi C; Cordini M; Simoni L; Cultrera S; Bardare M
Scand J Haematol Suppl; 1984; 40():359-65. PubMed ID: 6433462
[No Abstract] [Full Text] [Related]
20. Age distribution of Epstein-Barr virus, cytomegalovirus and rubella virus antibodies.
Lin KH; Chiang CH; Yang CS
Taiwan Yi Xue Hui Za Zhi; 1987 Dec; 86(12):1316-9. PubMed ID: 2832515
[No Abstract] [Full Text] [Related]
[Next] [New Search]
